Nile Pharma reports 14.8% YoY profit hike in 9 months

Updated 5/16/2022 1:52:00 PM

ArabFinanceEl Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) has posted a 14.77% year-on-year (YoY) increase in net profit after tax during the first nine months of the fiscal year (FY) 2021/2022, recording EGP 69.257 million, according to a filing to the Egyptian Exchange (EGX) on Monday.

The company’s operating revenue grew to EGP 677.282 million in the nine-month period ended March 31st, from EGP 621.102 million, the year before.

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.